Tanezumab In Osteoarthritis Of The Knee (2)

NCT00830063 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

832

Enrollment

INDUSTRY

Sponsor class

Conditions

Arthritis
Osteoarthritis

Interventions

BIOLOGICAL: tanezumab 10 mg
BIOLOGICAL: tanezumab 5 mg
DRUG: naproxen
OTHER: placebo

Sponsor

Pfizer